4. Jane, the CEO of a pharmaceutical company, has delegated the task of determining whether the firm should launch a new line of obesity-reducing pills. She instructs her subordinate to 1) assess the firm's current situation, 2) define all of the relevant variables, and 3) focus only on the issue of launching a new line when weighing any risks associated with the uncertainty of the outcome. What was unusual about this approach to weighing risk? a. Jane instructed her subordinate to weigh the risk against the uncertainty of the outcome. b. Jane instructed her subordinate to focus on only one issue, without taking a look at the other possible issues. c. Jane instructed her subordinate to assess the firm's current situation. d. Jane instructed her subordinate to define all of the relevant variables